-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals Q4 EPS $(0.41) Beats $(0.43) Estimate

Benzinga·03/26/2026 12:23:14
Listen to the news
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 5.09 percent. This is a 33.87 percent increase over losses of $(0.62) per share from the same period last year.